Mazmanian, Sarkis K.
Division of Biology and Biological Engineering,
United States
2025 Rank: 4115
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 88 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4115 | 4679 |
| Total Cites | 5359 | 5467 |
| H-index | 40 | 40 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 335 | 338 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 3734 | 3763 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3961 | 4021 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.36 |
| Self-Citation Percentage |
1.98%
|
|
Mazmanian, Sarkis K.
California Institute of Technology,
United States
2024 Rank: 4509
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 102 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4509 | 5220 |
| Total Cites | 4843 | 4927 |
| H-index | 38 | 38 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 312 | 314 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 3399 | 3433 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3675 | 3722 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.32 |
| Self-Citation Percentage |
1.70%
|
|
Mazmanian, Sarkis K.
California Institute of Technology,
United States
2023 Rank: 4050
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 106 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4050 | 4531 |
| Total Cites | 5417 | 5538 |
| H-index | 35 | 36 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 406 | 409 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 3791 | 3858 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3923 | 3989 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.39 |
| Self-Citation Percentage |
2.18%
|
|
Mazmanian, Sarkis K.
California Institute of Technology,
United States
2022 Rank: 3990
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 109 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3990 | 4622 |
| Total Cites | 4834 | 4939 |
| H-index | 36 | 36 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 426 | 432 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 3408 | 3441 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3480 | 3541 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.39 |
| Self-Citation Percentage |
2.13%
|
|
Mazmanian, Sarkis K.
California Institute of Technology,
United States
2021 Rank: 3829
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 101 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3829 | 4406 |
| Total Cites | 6783 | 6957 |
| H-index | 40 | 41 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 615 | 627 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 4785 | 4844 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4924 | 5020 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.39 |
| Self-Citation Percentage |
2.50%
|
|
Mazmanian, Sarkis K.
California Institute of Technology,
United States
2020 Rank: 3576
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 83 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3576 | 4119 |
| Total Cites | 4746 | 4893 |
| H-index | 35 | 35 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 502 | 509 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 3416 | 3469 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3386 | 3460 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.41 |
| Self-Citation Percentage |
3.00%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.